Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03795246 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

Study acronym: KSF2
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Mar 23, 2018 to Apr 12, 2018v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Jan 2022 to Jan 2028
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Mar 2030 to Jan 2028
    • Site details revised
    v3
  4. Primary completion date: Jan 2020 to Jan 2022
    • Study completion date: Jan 2030 to Mar 2030
    • Site contact updated
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Interventional research with low risks and constraints, prospective and monocentric on the assessment of long-term fertility in patients who underwent an adjuvant sequential chemotherapy with or without a controled ovarian hyperstimulation. This study follows a previous one called NCT 01614704.
Trial Details
NCT Number NCT03795246
Lead Sponsor Centre Oscar Lambret
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov